EMBO Molecular Medicine
From Wikipedia, the free encyclopedia
Academic journal
| Discipline | Molecular medicine |
|---|---|
| Language | English |
| Edited by | Philippe Sansonetti |
| Publication details | |
| History | 2009–present |
| Publisher | EMBO Press on behalf of the European Molecular Biology Organization |
| Frequency | Continuous |
| Yes | |
| License | Creative Commons Attribution License |
| 9.0 (2023) | |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt Paid subscription required) | |
| ISO 4 | EMBO Mol. Med. |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus · W&L | |
| ISSN | 1757-4676 (print) 1757-4684 (web) |
| LCCN | 2009243409 |
| OCLC no. | 971953346 |
| Links | |
EMBO Molecular Medicine is an open-access peer-reviewed medical journal covering research in molecular medicine.
The journal was published by Wiley-Blackwell together with the European Molecular Biology Organization since its launch in 2009, until December 2013, when EMBO Press was started.[1] According to the Journal Citation Reports , the journal had a 2023 impact factor of 9.0.[2]
References
[edit ]- ^ "EMBO announces the launch of EMBO Press". EMBO. Archived from the original on December 5, 2013. Retrieved April 5, 2017.
- ^ "EMBO Molecular Medicine". 2023 Journal Citation Reports (Science ed.). Clarivate. 2024 – via Web of Science.
External links
[edit ]
Stub icon 1 Stub icon 2
This article about a molecular and cell biology journal is a stub. You can help Wikipedia by expanding it.
See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.